Neubio
PrivateCompany Overview
Neubio is a therapeutic devices company that develops and manufactures cochlear implant solutions for individuals with severe to profound hearing loss.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Patient Engagement
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Neubio Comparables
Compare Neubio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| TODOC | 83% | |
| Hemideina | 79% | |
| Nurotron Biotechnology Co., Ltd. | 76% | |
Neubio Funding Rounds
Historical fundraising activity
Market signals
Structured signals derived from secondary market and firmographic data.
- May 1, 2025
Monthly visitors grew 74% MoM, reaching 440.
- Mar 21, 2025
Monthly visitors grew 172% MoM.
Neubio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Neubio's valuation, stock price, and market status.